Which (if any) of the supplements on the FLCCC protocols should be avoided by those with cancer?

Dr. Nathan Goodyear says that methylene blue should not be avoided when treating cancer patients. He also suggests using Vitamin C. He does say one who is treating cancer should avoid NAC and explains why. Dr. Paul Marik adds his thoughts on the use of Vitamin C, and its oxidative effects, as it relates to use during cancer treatment. Both doctors agree that many other supplements like Vitamin D, turmeric, etc are good to take while undergoing treatment for cancer.

View full webinar here: 
https://odysee.com/@FrontlineCovid19CriticalCareAlliance:c/Weekly_Webinar_Feb01:5

Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease. We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you. Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.
To donate online, click here:
https://covid19criticalcare.com/network-support/support-our-work/

To follow FLCCC, click here:
https://covid19criticalcare.com/follow-flccc-2/

To learn more about our protocols, click here:
https://covid19criticalcare.com/covid-19-protocols/

To register for weekly webinars, click here:
https://geni.us/FLCCC_Webinar_Register

To buy FLCCC gear, click here:
https://supportflccc.store/

Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
CSID: 3e26e6a0f3533d43

Content Managed by ContentSafe.co